The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells

Carbohydrate Polymers

Volumn 90, Issue 3, 2012, Pages 1323-1329

  Saengkrit, Nattika ^a   Sanitrum, Phakorn ^b   Woramongkolchai, Noppawan ^a   Saesoo, Somsak ^a   Pimpha, Nuttaporn ^a   Chaleawlert Umpon, Saowaluk ^a   Tencomnao, Tewin ^b   Puttipipatkhachorn, Satit ^c  

^a NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chitosan; Core shell nanoparticle; DNA delivery; Human cervical cancer cell line; Polyethyleneimine; siRNA delivery

Indexed keywords

CERVICAL CANCER CELLS; CORE/SHELL NANOPARTICLES; DNA DELIVERY; POLYETHYLENEIMINE; SIRNA DELIVERY;

CELL CULTURE; CELLS; CHITOSAN; DRUG THERAPY; ESTERS; GENE TRANSFER; ONCOGENIC VIRUSES; POLYETHYLENES; RNA; ZETA POTENTIAL;

NANOPARTICLES;

E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; METHACRYLIC ACID METHYL ESTER; NANOPARTICLE; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; POLYETHYLENEIMINE; PROTEIN E7; REPRESSOR PROTEIN; SMALL INTERFERING RNA;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; METABOLISM; PAPILLOMAVIRUS INFECTION; PARTICLE SIZE; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR; VIROLOGY;

CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; HUMAN PAPILLOMAVIRUS 16; HUMANS; METHYLMETHACRYLATE; NANOPARTICLES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PARTICLE SIZE; POLYETHYLENEIMINE; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84865639678     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2012.06.079     Document Type: Article

References (35)

1. W.F. Anderson Human gene therapy Nature 392 6679 Suppl. 1998 25 30
2. L.M. Alvarez-Salas, M.L. Benitez-Hess, and J.A. DiPaolo Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses Antiviral Therapy 8 4 2003 265 278
3. M. Bivas-Benita, S. Romeijn, H.E. Junginger, and G. Borchard PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium European Journal of Pharmaceutics and Biopharmaceutics 58 1 2004 1 6
4. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, and J. Peto Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group Journal of the National Cancer Institute 87 11 1995 796 802
5. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, and B. Demeneix A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine Proceedings of the National Academy of Sciences of the United States of America 92 16 1995 7297 7301
6. K. Butz, T. Ristriani, A. Hengstermann, C. Denk, M. Scheffner, and F. Hoppe-Seyler siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells Oncogene 22 38 2003 5938 5945
7. C.S. Divya, and M.R. Pillai Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis Molecular Carcinogenesis 45 5 2006 320 332
8. N. Dyson, P.M. Howley, K. Munger, and E. Harlow The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 4893 1989 934 937
9. W.T. Godbey, K.K. Wu, and A.G. Mikos Poly(ethylenimine) and its role in gene delivery Journal of Controlled Release 60 2-3 1999 149 160
10. V.A. Govan A novel vaccine for cervical cancer: Quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil) Journal of Therapeutics and Clinical Risk Management 4 1 2008 65 70
11. K. Grassmann, B. Rapp, H. Maschek, K.U. Petry, and T. Iftner Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA Journal of Virology 70 4 1996 2339 2349
12. G.J. Hannon RNA interference Nature 418 6894 2002 244 251
13. P.M. Howley, K. Munger, H. Romanczuk, M. Scheffner, and J.M. Huibregtse Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses Princess Takamatsu Symposia 22 1991 239 248
14. S. Inphonlek, N. Pimpha, and P. Sunintaboon Synthesis of poly(methyl methacrylate) core/chitosan-mixed-polyethyleneimine shell nanoparticles and their antibacterial property Colloids and Surfaces B: Biointerfaces 77 2 2010 219 226
15. S. Jeon, and P.F. Lambert Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis Proceedings of the National Academy of Sciences of the United States of America 92 5 1995 1654 1658
16. M.J. Khan, P.E. Castle, A.T. Lorincz, S. Wacholder, M. Sherman, and D.R. Scott The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice Journal of the National Cancer Institute 97 14 2005 1072 1079
17. R. Koivusalo, E. Krausz, H. Helenius, and S. Hietanen Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: Opposite effect of siRNA in combination with different drugs Molecular Pharmacology 68 2 2005 372 382
18. M.N. Kumar, R.A. Muzzarelli, C. Muzzarelli, H. Sashiwa, and A.J. Domb Chitosan chemistry and pharmaceutical perspectives Chemical Reviews 104 12 2004 6017 6084
19. K. Kunath, A. von Harpe, D. Fischer, H. Petersen, U. Bickel, and K. Voigt Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: Comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine Journal of Controlled Release 89 1 2003 113 125
20. Z.X. Liao, Y.C. Ho, H.L. Chen, S.F. Peng, C.W. Hsiao, and H.W. Sung Enhancement of efficiencies of the cellular uptake and gene silencing of chitosan/siRNA complexes via the inclusion of a negatively charged poly(gamma-glutamic acid) Biomaterials 31 33 2010 8780 8788
21. E. Mastrobattista, M.A. van der Aa, W.E. Hennink, and D.J. Crommelin Artificial viruses: A nanotechnological approach to gene delivery Nature Reviews Drug Discovery 5 2 2006 115 121
22. N. Pimpha, P. Sunintaboon, S. Inphonlek, and Y. Tabata Gene delivery efficacy of polyethyleneimine-introduced chitosan shell/poly(methyl methacrylate) core nanoparticles for rat mesenchymal stem cells Journal of Biomaterials Science Polymer Edition 21 2 2010 205 223
23. L.N. Putral, M.J. Bywater, W. Gu, N.A. Saunders, B.G. Gabrielli, and G.R. Leggatt RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin Molecular Pharmacology 68 5 2005 1311 1319
24. V. Rakkhithawatthana, P. Sanitrum, W. Sajomsang, P. Na Ubon, T. Tencomnao, and N. Saengkrit Investigation of gene transferring efficacy through nanopolyplex consisting of methylated N-(4-pyridinylmethyl) chitosan chloride and poly(ethylenimine) in human cell lines Carbohydrate Polymers 80 2010 276 284
25. D. Schaffert, and E. Wagner Gene therapy progress and prospects: Synthetic polymer-based systems Gene Therapy 15 16 2008 1131 1138
26. J. Schwock, N.A. Pham, M.P. Cao, and D.W. Hedley Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo Cancer Chemotherapy and Pharmacology 61 4 2008 669 681
27. S. Tan, B.M. Hougardy, G.J. Meersma, B. Schaap, E.G. de Vries, and A.G. van der Zee Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells Molecular Pharmacology 81 5 2012 701 709
28. T. Tencomnao, A. Apijaraskul, V. Rakkhithawatthana, S. Chaleawlert-umpon, N. Pimpa, and W. Sajomsang Gold/cationic polymer nano-scaffolds mediated transfection for non-viral gene delivery system Carbohydrate Polymers 84 2011 216 222
29. T. Tencomnao, V. Rakkhitawatthana, and K. Sukhontasing Evaluation of a novel luciferase reporter construct: A positive control plasmid for reporter gene assay African Journal of Biotechnology 7 2008 2124 2127
30. B. Urban-Klein, S. Werth, S. Abuharbeid, F. Czubayko, and A. Aigner RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo Gene Therapy 12 5 2005 461 466
31. M. von Knebel Doeberitz, C. Rittmüller, H.Z. Hausen, and M. dürst Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV e6-e7 anti-sense RNA International Journal of Cancer 51 5 1992 831 834
32. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide Journal of Pathology 189 1 1999 12 19
33. W. Walther, and U. Stein Viral vectors for gene transfer: A review of their use in the treatment of human diseases Drugs 60 2 2000 249 271
34. B.A. Werness, A.J. Levine, and P.M. Howley Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248 4951 1990 76 79
35. S.Y. Wong, J.M. Pelet, and D. Putnam Polymer systems for gene delivery - Past, present, and future Progress in Polymer Science 32 2007 799 837